Unlocking the secrets of Royal Jelly: from recent breakthroughs to novel drugs targeting Anaplastic Lymphoma Kinase

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1050593

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Nature is a source of incommensurable chemical diversity that throughout history have provided many useful bioactive compounds including anti-cancer drugs. Our recent results suggest that honeybees use royal jelly to regulate the expression of genes implicated in certain types of human cancer.The aim of this study is to identify inhibitors of cancer related genes in royal jelly and to understand the mechanism of their action. Our results could lead to novel combination therapies.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $348,763.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Epigenetics (incl. Genome Methylation and Epigenomics)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

DNA methylation | cancer control | drug development | epigenetics | gene expression | receptor signalling | signalling pathways

Related Links